Retrograde nerve growth factor signaling abnormalities and the pathogenesis of familial dysautonomia
Retrograde nerve growth factor signaling abnormalities and the pathogenesis of familial dysautonomia作者机构:Department of Pathology and Laboratory MedicineCedars-Sinai Medical CenterLos AngelesCAUSA Department of NeurologyDepartment of NeurosurgeryDepartment of Biomedical SciencesCedars-Sinai Medical CenterLos AngelesCAUSA
出 版 物:《Neural Regeneration Research》 (中国神经再生研究(英文版))
年 卷 期:2021年第16卷第9期
页 面:1795-1796页
核心收录:
学科分类:0710[理学-生物学] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 100204[医学-神经病学] 10[医学]
基 金:NCRR NIH HHS [K26 RR026099] Funding Source: Medline NICHD NIH HHS [R21 HD063078] Funding Source: Medline NIH HHS [K26 OD010945] Funding Source: Medline NINDS NIH HHS [R56 NS089626, R01 NS095894] Funding Source: Medline
主 题:al. pathogenesis impairment
摘 要:Familial dysautonomia(FD,OMIM 223900;also known as HSAN III or Riley-Day syndrome) is the most prevalent form of hereditary sensory and autonomic neuropathy(HSAN;Axelrod et al., 1974). Patients suffering from autonomic and sensory nervous system impairment have no available effective treatment and the average age of death is approximately 24 years.